•Vertex Pharmaceuticals has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10.0 billion.
•Cabot Corporation announced a leadership transition with Erica McLaughlin elected to succeed Sean Keohane as CEO effective October 1, 2026.
•Vornado Realty Trust reported a sharp decline in Q2 net income to $16.4 million from $743.8 million in the prior year, primarily due to a one-time gain in 2025.
•Newbridge Acquisition Limited announced the execution of a business combination agreement with Startech Group Inc., a life sciences technology company.
•Startech focuses on developing functional water and AI-powered healthcare technologies to enhance human longevity.
•Palantir Technologies raised its annual revenue forecast again, signaling strong demand for its data analytics software from government and commercial clients.
•Vertex Pharmaceuticals raised its annual revenue forecast driven by the strength of its cystic fibrosis drugs.
•San Francisco filed a lawsuit against Booking Holdings and other sites for allegedly misleading consumers into believing they were booking directly with hotels.
•The lawsuit alleges the sites used deceptive advertising to charge up to 85 percent more than official hotel rates.